請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26558
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴美淑 | |
dc.contributor.author | Hsu-Wen Chou | en |
dc.contributor.author | 周煦文 | zh_TW |
dc.date.accessioned | 2021-06-08T07:15:09Z | - |
dc.date.copyright | 2008-08-08 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-29 | |
dc.identifier.citation | 1. Lin T, Chou P, Lai MS, Tsai ST, Tai TY. Direct costs-of-illness of patients with diabetes mellitus in Taiwan. Diabetes Res Clin Pract 2001;54 Suppl 1:S43-6.
2. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva, World Health Organization (WHO/HTM/TB/2007.376). 3. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. Geneva, World Health Organization (WHO/HTM/TB/2008.393). 4. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172(9):1169-227. 5. Stalenhoef JE, Alisjahbana B, Nelwan EJ, et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2008;27(2):97-103. 6. Banerjee S, Banerjee M. Diabetes and tuberculosis interface. J Indian Med Assoc 2005;103(6):318, 20, 22 passim. 7. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007;45(4):428-35. 8. Balde NM, Camara A, Camara LM, Diallo MM, Kake A, Bah-Sow OY. Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis 2006;10(9):1036-40. 9. Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007;135(3):483-91. 10. Coker R, McKee M, Atun R, et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. Bmj 2006;332(7533):85-7. 11. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg 2006;100(3):191-9. 12. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53. 13. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28(9):2130-5. 14. Hegde HR. Diabetes mellitus, acquired immune deficiency syndrome and tuberculosis. Med Hypotheses 2005;64(5):1065. 15. Broxmeyer L. Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma. Med Hypotheses 2005;65(3):433-9. 16. 陳建仁教授等. 台灣地區高血壓、高血糖、高血脂盛行率調查; 2002. 17. 衛生署疾病管制局. 台灣結核病防治年報; 2007. 18. 行政院衛生署疾病管制局 http://www.cdc.gov.tw. (Accessed at 19. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76(6):529-33. 20. Lin S, Shen M, Sun Y. [Epidemiological characteristics of tuberculosis patients complicated with diabetes in Shanghai]. Zhonghua Jie He He Hu Xi Za Zhi 1998;21(8):504-6. 21. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001;120(5):1514-9. 22. Subhash HS, Ashwin I, Mukundan U, et al. Drug resistant tuberculosis in diabetes mellitus: a retrospective study from south India. Trop Doct 2003;33(3):154-6. 23. Perez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Vargas MH. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000;162(5):1738-40. 24. Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001;68(6):595-600. 25. Wang JY, Lee LN, Hsueh PR. Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 2005;9(7):777-83. 26. Shaikh MA, Singla R, Khan NB, Sharif NS, Saigh MO. Does diabetes alter the radiological presentation of pulmonary tuberculosis. Saudi Med J 2003;24(3):278-81. 27. Perez-Guzman C, Vargas MH, Torres-Cruz A, Perez-Padilla JR, Furuya ME, Villarreal-Velarde H. Diabetes modifies the male:female ratio in pulmonary tuberculosis. Int J Tuberc Lung Dis 2003;7(4):354-8. 28. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007;45(4):436-8. 29. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87(4):574-9. 30. Perez A, Brown HS, 3rd, Restrepo BI. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg 2006;74(4):604-11. 31. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006;55(1):19-26. 32. Dyck RF, Klomp H, Marciniuk DD, et al. The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people. Can J Public Health 2007;98(1):55-9. 33. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004;27(7):1584-90. 34. Alisjahbana B, van Crevel R, Sahiratmadja E, et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006;10(6):696-700. 35. Shetty N, Shemko M, Vaz M, D'Souza G. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis 2006;10(1):80-6. 36. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3(3):228-45. 37. Chiang CY, Enarson DA, Yang SL, Suo J, Lin TP. The impact of national health insurance on the notification of tuberculosis in Taiwan. Int J Tuberc Lung Dis 2002;6(11):974-9. 38. 傳染病防治法. In; 中華民國九十六年七月十八日華總一義字第0九六000九一0一一號令修正公布全文七十七條. 39. 江振源、張正達、張睿詒、李錦田、黃瑞明. 台南地區歸因於病人與醫療機構之結核病診斷與治療之延遲之時間及因素分析研究: 衛生署胸腔病院; 2003 2003年01月01日 至 2003年12月31日. Report No.: DOH92-DC-1039. 40. Chiang CY, Chang CT, Chang RE, Li CT, Huang RM. Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis 2005;9(9):1006-12. 41. 曹世明. 醫院通報延遲之因素分析研究. 台中: 中山醫學大學附設醫院; 2004 2004年3月1日至2004年12月31日. Report No.: DOH93-DC-1014. 42. 蔡文正、龔佩珍、胡曉雲、廖凱平. 結核病患失落之因素分析研究. 台中: 中國醫藥大學; 2003 2003年01月01日 至 2003年12月31日. Report No.: DOH92-DC-1038. 43. 胡曉雲, 蔡文正, 龔佩珍. 肺結核病患未完成治療原因探討. 臺灣公共衛生雜誌:348-59. 44. 江振源、陸坤泰、林道平、呂喬洋、吳怡君. 結核病人改診斷與死亡之因素分析: 中華民國防痨協會; 2005 2005年1月1日至2005年12月31日. Report No.: DOH94-DC-1022. 45. 白冠壬、李俊年、吳麗均. 在台灣外籍人士之結核病2000-2004. 台北市: 萬芳醫院; 2006 2006年1月1日至2006年12月31日. Report No.: DOH95-DC-1013. 46. Bai KJ, Chiang CY, Lee CN, Chang JH, Wu LC, Yu MC. Tuberculosis Among Foreign-born Persons in Taiwan, 2002-2005. Journal of the Formosan Medical Association = Taiwan yi zhi 2008;107(5):389-95. 47. 龔佩珍、蔡文正、張淳堆、施純明、宋育民、沈光漢. 糖尿病對結核病之相對危險性及合併糖尿病結核病患者之需求調查-以中部地區為例. 台中: 健康暨管理學院; 2004 2004年1月1日至2004年12月31日. Report No.: DOH93-DC-1013. 48. 龔佩珍、蔡文正、沈光漢、李仁智、張伍隆、彭安娜. 台灣人口密集地區機構結核病患追蹤列管情形∼以長期照護機構與監獄為例: 亞洲大學; 2006 2006年1月1日至2006年12月31日. Report No.: DOH95-DC-1012. 49. 李永盛、黃貝琴、柯靜芬、林玉梅、王淑芬、李祈甫、施仁興、楊治國、李仁智. 高發病地區家族性結核病傳染模式探討. 花蓮: 疾病管制局第六分局; 2007 2007年1月1日至2007年12月31日. Report No.: DOH96-DC-2034. 50. 蔡文正、龔佩珍、沈光漢、施純明. 健保結核病專案對於結核病防治工作的影響評估. 台中: 中國醫藥大學; 2005 2005年1月1日至2005年12月31日. Report No.: DOH94-DC-1021. 51. Nucleic acid amplification tests for tuberculosis. Mmwr 1996;45(43):950-2. 52. Update: Nucleic acid amplification tests for tuberculosis. Mmwr 2000;49(26):593-4. 53. Roth A, Schaberg T, Mauch H. Molecular diagnosis of tuberculosis: current clinical validity and future perspectives. Eur Respir J 1997;10(8):1877-91. 54. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161(4 Pt 1):1376-95. 55. Yan JJ, Huang AH, Tsai SH, Ko WC, Jin YT, Wu JJ. Comparison of the MB/BacT and BACTEC MGIT 960 system for recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis 2000;37(1):25-30. 56. 陸坤泰, 行政院衛生署疾病管制局. 結核病診治指引 Taiwan Guideline on TB Diagnosis Treatment. 台北市: 行政院衛生署疾病管制局; 2006. 57. Toman K, Frieden T, Toman K, World Health O. Toman's tuberculosis : case detection, treatment, and monitoring : questions and answers. Geneva: World Health Organization; 2004. 58. Hanna BA, Ebrahimzadeh A, Elliott LB, et al. Multicenter Evaluation of the BACTEC MGIT 960 ystem for Recovery of Mycobacteria. In; 1999:748-52. 59. Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 2003;7(6):569-74. 60. 林正清. 台灣全民健康保險糖尿病資料庫有關之研究: 國立台灣大學; 2003. 61. 賴美淑. 以健保申報醫療利用資料,建立台灣糖尿病病人世代追蹤實證研究計畫: 行政院衛生署九十二年度委託研究計畫; 2003. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26558 | - |
dc.description.abstract | 糖尿病和結核病的研究,大多偏重於結核病患中合併糖尿病之分析,亦或是針對特定族群、以醫療院所為背景的研究,缺乏以糖尿病族群為研究對象之前瞻性世代追蹤研究。因此,本研究欲藉台灣的全民健康保險資料庫及疾病管制局之中央傳染病通報系統,藉二次資料庫分析,了解全國糖尿病合併結核病之發生危險比、死亡率,及其細菌學診斷通報分析。
本研究由行政院衛生署九十四年度委託之三年研究計劃,建立之2000年全民健康保險糖尿病世代中,抽選出之研究樣本154,347人為主要研究對象。追蹤年度就醫紀錄中有結核病相關診斷碼之病患,同時串聯疾病管制局之結核病通報系統、死亡檔,確認每年結核病新發個案並追蹤存活人數。使用存活分析(Survival analysis)方式進行分析,以Life table analysis、log-rank test檢定不同分層之存活曲線是否有差異,使用Cox Proportional Hazard Model計算不同影響因子危險比(Hazard Ratio),分析相關因子包括性別、年齡、地理區域,並進一步以Time-Dependent Covariate方式校正Cox’s model之存活分析。 此糖尿病世代中,糖尿病病患罹患結核病的年發生率五年平均為每千人3.39,經年齡標準化後為每千人1.91,約為我國2006年全國結核病新案發生率每千人0.67的2.9倍,男性糖尿病患的結核病發生率約為女性的2.3倍,全國人口發生率的七倍。痰塗片陽性個案每年有34.6%~46.6%,五年整體發生率之地理分布由高至低則為高屏分局、東區分局、中區分局、南區分局、北區分局、台北分局。年死亡率自2001年至2005年分別為每千人158.90、189.66、182.24、180.85、222.22。糖尿病患合併結核病之相關因素部份,以多變項分析結果呈現,男性糖尿病患合併發生結核病的危險為女性的2.39倍, 65歲以上危險比最高(HR: 7.31, p=0.005),高屏分局轄區內危險比為 (HR: 1.74, p<0.0001),其次為東區分局(HR: 1.62, p<0.0001)。在控制性別、年齡、居住區域及交互作用的情況下,合併結核病對糖尿病患存活的危險為2.36倍(p <0.0001)。 以次級資料追蹤研究顯示,我國糖尿病患發生結核病的機率為一般族群的2.9倍之多,重要之相關因素為年齡、性別、居住區域等,研究結果對未來結核病之防治策略提供了重要的參考資料。 | zh_TW |
dc.description.abstract | Current literature about the diabetes and tuberculosis co-infection is limited to studies on diabetes among tuberculosis patients, or hospital-based studies on specific populations. Therefore, the objectives of this study are to estimate the incidence and mortality of a diabetes cohort with tuberculosis co-infection in Taiwan using the National Health Insurance database and the Central Communicable disease notification system of the Center of Disease Control(CDC), and to compare survival between diabetics with tuberculosis and those without, and define the high risk group in these co-morbid population.
We followed the diabetes cohort sample (n=154347) for five years starting in 2001, traced diagnosis records of diabetes patients (ICD-9-CM code 010~018) from the National Health Insurance database with the tuberculosis records from the Central Communicable Disease notification system of CDC. We also followed diabetics with tuberculosis to track new tuberculosis cases per year and to confirm death status using the death registration system. Survival analysis using the life table method and the log-rank test was conducted to compare the survival curves, Cox Proportional Hazard Model for testing the hazard ratios among the potential risk factors, and included time-dependent covariate to adjust for the Cox’s model. Incidence of co-morbidity with tuberculosis in the five-year diabetes cohort is 3.39 per thousand persons on average, and 1.91 per thousand persons after adjusting for age, which is 2.9 times higher than the incidence of tuberculosis (0.67 per thousand persons) of the general Taiwan population. Tuberculosis incidence in male diabetics is approximately 2.3 times that of female diabetics, and 7 times higher than that of the Taiwan population. About 34.6%~46.6% of the diabetes cohort are tuberculosis smear positives every year between 2001 and 2005. Mortality rates for the diabetes cohort from 2001 to 2005 are 158.90, 189.66, 182.24, 180.85, and 222.22 per thousand persons per year, respectively. The hazard ratio for male diabetics co-morbidity with tuberculosis is 2.39 times that of female diabetics, and diabetes patients of age 65 and over have the highest risk of tuberculosis co-morbidity with diabetes (HR: 7.31, p=0.005). After controlling for age, gender, and living area, diabetics with tuberculosis have a higher risk of death compared to diabetics without tuberculosis co-infection (HR: 2.36, p<0.0001). Using secondary database, our research indicates that diabetes patients are almost 3 times more likely to be co-infected with tuberculosis, after adjusting for age, gender, and living area. The results of this study will provide the critical information needed to create strategy in tuberculosis control in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T07:15:09Z (GMT). No. of bitstreams: 1 ntu-97-R95846007-1.pdf: 714858 bytes, checksum: 56914b331e3f11098becefc67c657861 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 摘要 I
Abstract III 目 錄 V 表目錄 VII 圖目錄 IX 第一章 前言 1 第一節 研究背景 1 第二節 研究目的 2 第二章 文獻探討 3 第一節 台灣及國際糖尿病及結核病流行病學研究 3 第二節 結核病與糖尿病並存之相關研究 4 第三節 疾病管制局之中央傳染病追蹤管理系統 7 第四節 疾管局建立「中央傳染病追蹤管理系統」中結核病之相關研究 9 第五節 結核病細菌學診斷工具探討 17 第六節 糖尿病研究世代追蹤資料建立 18 第三章 研究材料與方法 20 第一節 次級資料庫來源及主要變項 20 第二節 研究變項定義 23 一、糖尿病患定義 23 二、結核病患研究對象選取之定義 24 三、人口學變項 25 四、細菌學診斷分析 26 五、存活分析 26 第三節 研究方法與架構 27 第四節 統計方法 29 第四章 研究結果 30 第一節 結核病診斷在健保申報資料庫與疾管局結核病通報資料庫之相關性分析..……………………………………………………………………………...30 一、「健保申報資料」與「結核病診斷與通報資料」之描述性分析 30 二、結核病診斷在健保申報資料及疾管局通報資料之比較 30 第二節 糖尿病世代中結核病患之細菌學診斷分析 36 第三節 糖尿病世代追蹤合併結核病之發生率與死亡率 38 第四節 糖尿病患合併發生結核病之相關因素分析 47 第五節 糖尿病患有無合併結核病之存活分析 52 第五章 討論 60 參考文獻 63 | |
dc.language.iso | zh-TW | |
dc.title | 以次級資料追蹤糖尿病世代分析結核病之發生與存活 | zh_TW |
dc.title | Tuberculosis Incidence and Survival Analysis in Diabetes Cohort-Using Secondary Database | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 簡國龍,許銘能,葉彥伯,郭旭崧 | |
dc.subject.keyword | 糖尿病,結核病,世代研究,存活分析,台灣, | zh_TW |
dc.subject.keyword | Diabetes,Tuberculosis,Cohort study,Survival analysis,Taiwan, | en |
dc.relation.page | 68 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2008-07-29 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 698.1 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。